Ruaa Al-Ward, Vania Balderrama Brondani, Sahar Sawani, Cheryl L Potter, Guofan Xu, Steven G Waguespack, Jeena Varghese, Mouhammed Amir Habra, Yang Lu, Camilo Jimenez
PATIENTS AND METHODS: The primary endpoints were objective response rate (ORR) and disease control rate (DCR). Secondary endpoints were duration of response, blood pressure control, safety, overall and progression-free survival rates, MIBG uptake, and correlations with genetic background. RESULTS: The study included 25 patients. Twenty-four patients had distant metastases, 17 (68%) had hormonally active tumors, and 13 (52%) had previously received antineoplastic treatment...
April 17, 2024: Clinical Nuclear Medicine